These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14551172)

  • 1. Does the kinin system mediate in cardiovascular abnormalities? An overview.
    Sharma JN
    J Clin Pharmacol; 2003 Nov; 43(11):1187-95. PubMed ID: 14551172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.
    Sharma JN
    Arch Med Res; 2006 Apr; 37(3):299-306. PubMed ID: 16513476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases.
    Sharma JN; Thani RB
    IDrugs; 2004 Oct; 7(10):926-34. PubMed ID: 15478018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular activities of the bradykinin system.
    Sharma JN
    ScientificWorldJournal; 2008 Apr; 8():384-93. PubMed ID: 18454246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinin system in hypertensive pathophysiology.
    Sharma JN
    Inflammopharmacology; 2013 Feb; 21(1):1-9. PubMed ID: 22527353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kallikrein-kinin pathways in hypertension and diabetes.
    Sharma JN; Narayanan P
    Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Adam A; Blais C; Loute G
    Nephrologie; 2000; 21(4):163-72. PubMed ID: 10976431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinins in the cardiovascular system.
    Schölkens BA
    Immunopharmacology; 1996 Jun; 33(1-3):209-16. PubMed ID: 8856152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors?
    Marceau F
    Can J Cardiol; 1997 Feb; 13(2):187-94. PubMed ID: 9070170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and the bradykinin system.
    Sharma JN
    Curr Hypertens Rep; 2009 Jun; 11(3):178-81. PubMed ID: 19442326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists.
    Sharma JN; Al-Sherif GJ
    ScientificWorldJournal; 2006 Oct; 6():1247-61. PubMed ID: 17041716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.
    Westermann D; Schultheiss HP; Tschöpe C
    Int Immunopharmacol; 2008 Feb; 8(2):148-54. PubMed ID: 18182218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
    Madeddu P; Emanueli C; El-Dahr S
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):208-21. PubMed ID: 17389890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin receptor ligands: therapeutic perspectives.
    Marceau F; Regoli D
    Nat Rev Drug Discov; 2004 Oct; 3(10):845-52. PubMed ID: 15459675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinins--characteristics and role in the circulatory system].
    Gabrylewicz B; Tendera M
    Pol Merkur Lekarski; 2004 Dec; 17(102):547-9. PubMed ID: 15771118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin system, renal function and hypertensive diseases.
    Margolius HS
    Prog Biochem Pharmacol; 1980; 17():116-22. PubMed ID: 6908057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.